[1]胡艳敏 刘赛哲 朱慎慎 刘阳 吴照科.左心耳排空速度对非瓣膜性心房颤动患者射频导管消融术后晚期复发的预测意义[J].心血管病学进展,2024,(12):1127.[doi:10.16806/j.cnki.issn.1004-3934.2024.12.016]
　HU Yanmin,LIU Saizhe,ZHU Shenshen,et al.The Prognostic Significance of Left Atrial Appendage Emptying Velocity in Predicting Late Recurrence After Radiofrequency Catheter Ablation in Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2024,(12):1127.[doi:10.16806/j.cnki.issn.1004-3934.2024.12.016]
点击复制

左心耳排空速度对非瓣膜性心房颤动患者射频导管消融术后晚期复发的预测意义()
分享到：

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2024年12期
页码:
1127
栏目:
论著
出版日期:
2024-12-25

文章信息/Info

Title:
The Prognostic Significance of Left Atrial Appendage Emptying Velocity in Predicting Late Recurrence After Radiofrequency Catheter Ablation in Patients with Atrial Fibrillation
作者:
胡艳敏1 刘赛哲2 朱慎慎1 刘阳3 吴照科1
(1.郑州大学第二附属医院,河南 郑州 450014;2.中国人民解放军总医院第一医学中心,北京 100039;3.中国人民解放军联勤保障部队第九八九医院,河南 洛阳 471000)
Author(s):
HU Yanmin1; LIU Saizhe2; ZHU Shenshen1; LIU Yang3; WU Zhaoke1
(1.The Second Affiliated Hospital of Zhengzhou University,Zhengzhou 450014 ,Henan,China;2.The First Medical Center of the General Hospital of the People’s Liberation Army,Beijing 100039 ,China;3.989th Central Hospital of PLA,Luoyang 471000,Henan,China)
关键词:
非瓣膜性心房颤动; 射频导管消融; 左心耳排空速度; 晚期复发
Keywords:
Nonvalvular atrial fibrillation; Radiofrequency catheter ablation; Left atrial appendage emptying velocity; Late recurrence
DOI:
10.16806/j.cnki.issn.1004-3934.2024.12.016
摘要:
目的 探讨左心耳排空速度（LAAEV）对非瓣膜性心房颤动（NVAF）患者射频导管消融(RFCA)术后晚期复发的临床预测价值。 方法 回顾性分析2020年1月—2023年5月在中国人民解放军总医院第一医学中心心内科入院并首次行RFCA的217例NVAF患者的临床资料,通过术后门诊复查、再次入院、电话等方式随访术后复发情况。根据RFCA术后3个月之后是否复发，将研究对象分成复发组（64例）和未复发组（153例）。统计两组患者一般资料并进行组间比较，将差异有统计学意义的因素纳入单因素和多因素logistic回归模型进一步分析，得出LAAEV是否为NVAF患者RFCA术后晚期复发的独立危险因素的结论，并根据ROC曲线及曲线下面积（AUC）分析该因素对RFCA术后晚期复发的预测价值。结果 复发组在持续性心房颤动、病程、 N末端脑钠肽前体、早期复发均高于未复发组，而LAAEV比未复发组低，差异有统计学意义（P＜0.05），logistic回归分析可见LAAEV与NVAF患者RFCA术后晚期复发独立相关(P＜0.05），绘制ROC曲线显示AUC为0.661,临界值为0.348，灵敏度为68.8%，特异度为66.0%。结论 LAAEV是NVAF患者RFCA术后晚期复发的一个独立危险因素，且具有较显著的预测价值。
Abstract:
Objective To investigate the clinical predictive value of left auricular emptying velocity (LAAEV) for late recurrence in patients with nonvalvular atrial fibrillation (NVAF) undergoing radiofrequency catheter ablation (RFCA). Methods Retrospective analysis of the clinical data of 217 patients with NVAF who presented to the Department of Cardiology of the First Medical Center of the General Hospital of the People’s Liberation Army (301 Hospital) from January 2020 to May 2023 and underwent RFCA for the first time. The recurrence of AF after RFCA was followed up by outpatient review,re-hospitalization,and telephone call. According to whether recurred after 3 months,the subjects were divided into a recurrence group (64 cases) and a non-recurrence group (153 cases) . The general data of the two groupsof patients were counted and compared between the two groups. The factors with statistically significant differences were included in the univariate and multivariate logistic regression models for further analysis to conclude whether LAAEV was an independent risk factor for late recurrence after radiofrequency catheter ablation in NVAF patients,and the predictive value of LAAEV in late recurrence after radiofrequency catheter ablation was analyzed according to ROC curve and AUC value. Results The levels of persistent atrial fibrillation,duration of disease,N-terminal pro-brain natriuretic peptide and early recurrence in the recurrent group were higher than those in the non-recurrent group,while LAAEV was lower than that in the non-recurrent group,and the differences were statistically significant ( P＜0.05). logistic regression analysis showed that LAAEV was independently associated with late recurrence after RFCA in patients with nonvalvular atrial fibrillation (P＜0.05)。The ROC curve shows that the AUC is 0.661,the cutoff is 0.348,the sensitivity is 68.8%,and the specificity is 66.0%. Conclusion LAAEV is an independent risk factor for late recurrence after RFCA in NVAF patients,with significant predictive value.

参考文献/References:

[1]Joglar JA,Chung MK,Armbruster AL,et al. 2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation:a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines[J]. Circulation,2024,149(1):e1-e156.

[2]Hindricks G,Potpara T,Dagres N,et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS):The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC[J]. Eur Heart J,2021,42(5):373-498.

[3]Han S,Jia R,Cen Z,et al. Early rhythm control vs. rate control in atrial fibrillation:a systematic review and meta-analysis[J]. Front Cardiovasc Med,2023,10:978637.

[4]Trenkwalder T,Grebmer C,Tydecks M,et al. Role of the ambulatory assessed apnea-hypopnea index for predicting recurring atrial fibrillation after ablation therapy[J]. Am J Cardiol,2021,149:36-41.

[5]Erhard N,Metzner A,Fink T. Late arrhythmia recurrence after atrial fibrillation ablation:incidence,mechanisms and clinical implications[J]. Herzschr Elektrophys,2022,33(1):71-76.

[6]Luo Y,Tang Y,Huang W,et al. Age,creatinine,and ejection fraction (ACEF) score as predictive values for late non-valvular atrial fibrillation recurrence after radiofrequency ablation[J]. Clin Exp Hypertens,2023,45(1):2207784.

[7]Ding B,Liu P,Zhang F,et al. Predicting values of neutrophil-to-lymphocyte ratio (NLR),high-sensitivity C-reactive protein (hs-CRP),and left atrial diameter (LAD) in patients with nonvalvular atrial fibrillation recurrence after radiofrequency ablation[J]. Med Sci Monit,2022,28:e934569.

[8]Calkins H,Hindricks G,Cappato R,et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation[J]. Heart Rhythm,2017,14(10):e275-e444.

[9]Simon J,El Mahdiui M,Smit JM,et al. Left atrial appendage size is a marker of atrial fibrillation recurrence after radiofrequency catheter ablation in patients with persistent atrial fibrillation[J]. Clin Cardiol,2022,45(3):273-281.

[10]Ha?ssaguerre M,Shah DC,Ja?s P,et al. Electrophysiological breakthroughs from the left atrium to the pulmonary veins[J]. Circulation,2000,102(20):2463-2465.

[11]Lin WS,Tai CT,Hsieh MH,et al. Catheter ablation of paroxysmal atrial fibrillation initiated by non-pulmonary vein ectopy[J]. Circulation,2003,107(25):3176-3183.

[12]Fukushima K,Fukushima N,Ejima K,et al. Left atrial appendage flow velocity and time from P-wave onset to tissue Doppler-derived A’ predict atrial fibrillation recurrence after radiofrequency catheter ablation[J]. Echocardiography,2015,32(7):1101-1108.

[13]Iwasaki YK,Nishida K,Kato T,et al. Atrial fibrillation pathophysiology:implications for management[J]. Circulation,2011,124(20):2264-2274.

[14]Kizilirmak F,Demir GG,Gokdeniz T,et al. Changes in electrocardiographic P wave parameters after cryoballoon ablation and their association with atrial fibrillation recurrence[J]. Ann Noninvasive Electrocardiol,2016,21(6):580-587.

[15]Saleh K,Haldar S. Atrial fibrillation:a contemporary update[J]. Clin Med (Lond),2023,23(5):437-441.

[16]Calkins H,Hindricks G,Cappato R,et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation:executive summary[J]. Europace,2018,20(1):157-208.

[17]Kirchhof P,Benussi S,Kotecha D,et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS[J]. Europace,2016,18(11):1609-1678.

[18]Mujovic NM,Marinkovic MM,Potpara TS,et al. Catheter ablation of lone atrial fibrillation[J]. Curr Pharm Des,2015,21(5):591-612.

[19]Hussein AA,Saliba WI,Martin DO,et al. Natural history and long-term outcomes of ablated atrial fibrillation[J]. Circ Arrhythm Electrophysiol,2011,4(3):271-278.

[20]Mohanty S,Mohanty P,di Biase L,et al. Impact of metabolic syndrome on procedural outcomes in patients with atrial fibrillation undergoing catheter ablation[J]. J Am Coll Cardiol,2012,59(14):1295-1301.

[21]Shah AN,Mittal S,Sichrovsky TC,et al. Long-term outcome following successful pulmonary vein isolation:pattern and prediction of very late recurrence[J]. J Cardiovasc Electrophysiol,2008,19(7):661-667.

[22]Liang JJ,Dixit S,Santangeli P. Mechanisms and clinical significance of early recurrences of atrial arrhythmias after catheter ablation for atrial fibrillation[J]. World J Cardiol,2016,8(11):638-646.

[23]Patti G,Pengo V,Marcucci R,et al. The left atrial appendage:from embryology to prevention of thromboembolism[J]. Eur Heart J,2017,38(12):877-887.

[24]Handke M,Harloff A,Hetzel A,et al. Left atrial appendage flow velocity as a quantitative surrogate parameter for thromboembolic risk:determinants and relationship to spontaneous echocontrast and thrombus formation—A transesophageal echocardiographic study in 500 patients with cerebral ischemia[J]. J Am Soc Echocardiogr,2005,18(12):1366-1372.

[25]Kiedrowicz RM,Wielusinski M,Wojtarowicz A,et al. Left and right atrial appendage functional features as predictors for voltage-defined left atrial remodelling in patients with long-standing persistent atrial fibrillation[J]. Heart Vessels,2021,36(6):853-862.

[26]Thotamgari SR,Sheth AR,Ahmad J,et al. Low left atrial appendage emptying velocity is a predictor of atrial fibrillation recurrence after catheter ablation[J]. J Cardiovasc Electrophysiol,2022,33(8):1705-1711.

[27]Kim MN,Lee JJ,Kim SA,et al. The difference of predictors for recurrence after catheter ablation of non-paroxysmal atrial fibrillation according to follow-up period[J]. Int Heart J,2014,55(4):312-318.

[28]Chen P,Shi Y,Ju J,et al. Left atrial appendage flow velocity predicts recurrence of atrial fibrillation after catheter ablation:a systematic review and meta-analysis[J]. Front Cardiovasc Med,2022,9:971848.

相似文献/References:

[1]彭金华,王平,胡婧,等.左心耳封堵术对非瓣膜性心房颤动患者心脏利尿钠肽分泌功能的影响[J].心血管病学进展,2019,(6):873.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.009]
　PENG Jinhua,WANG PingHU Jing,YANG Jingqi,et al.Effect of Left Atrial Appendage Closure on Cardiac Natriuretic Peptide Secretion in Patients with Nonvalvular Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2019,(12):873.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.009]
[2]王皎.室性期前收缩性心肌病诊疗进展[J].心血管病学进展,2020,(6):563.[doi:10.16806/j.cnki.issn.1004-3934.2020.06.001]
　WANG Jiao.Diagnosis and Treatment of Premature Ventricular Contraction-induced Cardiomyopathy[J].Advances in Cardiovascular Diseases,2020,(12):563.[doi:10.16806/j.cnki.issn.1004-3934.2020.06.001]
[3]于春鑫 孙姣 孙源君 尹晓盟.心房颤动导管消融相关心房食管瘘的研究进展[J].心血管病学进展,2020,(7):691.[doi:10.16806/j.cnki.issn.1004-3934.2020.07.005]
　YU Chunxin,SUN Jiao,SUN Yuanjun,et al.Atrioesophageal Fistula Associated with Catheter Ablation of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2020,(12):691.[doi:10.16806/j.cnki.issn.1004-3934.2020.07.005]
[4]金铁托 阮中宝.左心耳封堵术对患者系统内稳态的影响[J].心血管病学进展,2020,(12):1268.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.011]
　JIN Tietuo,RUAN Zhongbao.Effect of Left Atrial Appendage Closure on Systemic Homeostasis in Patients[J].Advances in Cardiovascular Diseases,2020,(12):1268.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.011]
[5]欧振宏 陈芸霖 殷跃辉.盐水灌注导管在肾去交感神经消融术中的应用[J].心血管病学进展,2021,(7):637.[doi:10.16806/j.cnki.issn.1004-3934.2021.07.015]
　OU Zhenhong,CHEN Yunlin,YIN Yuehui.Application of Saline-Irrigated Catheter in?span>Renal Sympathetic Denervation[J].Advances in Cardiovascular Diseases,2021,(12):637.[doi:10.16806/j.cnki.issn.1004-3934.2021.07.015]
[6]邓蕊 李洪仕 蔡衡.左心耳封堵术对非瓣膜性心房颤动合并冠状动脉性心脏病的价值[J].心血管病学进展,2022,(11):966.[doi:10.16806/j.cnki.issn.1004-3934.2022.11.002]
　DENG Rui,LI Hongshi,CAI Heng.Value of Left Atrial Appendage Closure on Non-Valvular Atrial Fibrillation with Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2022,(12):966.[doi:10.16806/j.cnki.issn.1004-3934.2022.11.002]
[7]陈清勇 辛艳峰 杨庆.改良的“大针套小针”干性心包穿刺术用于心外膜消融通路建立的有效性及安全性研究[J].心血管病学进展,2023,(4):371.[doi:10.16806/j.cnki.issn.1004-3934.2023.04.018]
　CHEN Qingyong,XIN Yanfeng,YANG Qing.Study on the Effectiveness and Safety of Modified Needle in Needle Dry Pericardiocentesis for Epicardial Access[J].Advances in Cardiovascular Diseases,2023,(12):371.[doi:10.16806/j.cnki.issn.1004-3934.2023.04.018]
[8]孙建英 魏飞宇 范洁.消融指数指导下高功率短时程消融对房颤射频导管消融术后食管损伤的研究进展[J].心血管病学进展,2023,(5):434.[doi:10.16806/j.cnki.issn.1004-3934.2022.05.012]
　SUN Jianying,WEI Feiyu,FAN Jie.High-Power Short-Duration Ablation Guided by Ablation Index for Esophageal Injury After Radiofrequency Ablation of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2023,(12):434.[doi:10.16806/j.cnki.issn.1004-3934.2022.05.012]
[9]秦可隽?姜述斌.左心耳封堵术对非瓣膜性心房颤动患者左心功能影响的研究进展[J].心血管病学进展,2024,(5):425.[doi:10.16806/j.cnki.issn.1004-3934.2024.05.010]
　QIN KejuanJIANG Shubin.Effects of Left Atrial Appendage Closure on Left Heart Function in Patients with Nonvalvular Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2024,(12):425.[doi:10.16806/j.cnki.issn.1004-3934.2024.05.010]
[10]许溪麟 李小明.艾多沙班在心血管疾病应用的研究进展[J].心血管病学进展,2024,(5):451.[doi:10.16806/j.cnki.issn.1004-3934.2024.05.016]
　XU Xilin,LI Xiaoming.Application of Edoxaban in Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2024,(12):451.[doi:10.16806/j.cnki.issn.1004-3934.2024.05.016]

更新日期/Last Update: 2025-01-08